Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 5/20 | 0.79 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | PLK1 | P53350 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175191 | 0.94 | TP53 (0.77) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL8081583 | 0.93 | RARB (0.90) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL7336812 | 0.93 | RARB (0.90) | RARBTP53TSHRPLA2G4BPKM | |
| Hydrochloric Acid SCHEMBL6560957 | 0.93 | TP53 (0.74) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL2356103 | 0.92 | RARB (0.68) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL3074389 | 0.90 | RARB (0.97) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL2490183 | 0.90 | RARB (0.97) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL13828471 | 0.89 | RARB (0.83) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL8569877 | 0.89 | PKM (0.78) | RARBTP53TSHRPLA2G4BPKM | |
| SCHEMBL4185457 | 0.88 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2727947-B1 | COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING HARDENED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2017-03-15 | — | — | EP | disclosed |
| EP-2555046-B1 | POLYMER FOR USE IN A LIQUID-CRYSTAL ALIGNMENT LAYER | DAINIPPON INK & CHEMICALS (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
| US-6331521-B1 | BETA-1,3-GLUCAN SYNTHASE INHIBITORS; PNEUMOCYSTIS PNEUMONIA INFECTION TREATMENT; FUNGICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-12-18 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-0983297-A1 | NEW ECHINOCANDINE DERIVATIVES WITH ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-03-08 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| WO-1998052967-A1 | NEW ECHINOCANDIDE DERIVATIVES WITH ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-26 | — | — | WO | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
| US-4225454-A | Ortho-cyanophenyl biphenylcarboxylate liquid crystal esters and mixtures thereof | HUGHES AIRCRAFT COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4136053-A | BIPHENYL ESTERS AND LIQUID CRYSTALLINE MIXTURES COMPRISING THEM | MERCK PATENT GESELLSCHAFT MIT BESCHANKTER HAFTUNG (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4065489-A | Biphenyl esters and liquid crystalline mixtures comprising them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | RARB 142/4885TP53 4770/4885TSHR 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.